Published in Artif Intell Med on August 01, 2000
Applications of machine learning in cancer prediction and prognosis. Cancer Inform (2007) 2.31
A gradient boosting algorithm for survival analysis via direct optimization of concordance index. Comput Math Methods Med (2013) 0.97
Multicenter Comparison of Machine Learning Methods and Conventional Regression for Predicting Clinical Deterioration on the Wards. Crit Care Med (2016) 0.93
A classification framework applied to cancer gene expression profiles. J Healthc Eng (2013) 0.89
Developing EHR-driven heart failure risk prediction models using CPXR(Log) with the probabilistic loss function. J Biomed Inform (2016) 0.86
A Naive Bayes machine learning approach to risk prediction using censored, time-to-event data. Stat Med (2015) 0.80
Markov models in medical decision making: a practical guide. Med Decis Making (1994) 8.14
Designing medical informatics research and library--resource projects to increase what is learned. J Am Med Inform Assoc (1995) 3.74
The Markov process in medical prognosis. Med Decis Making (1983) 3.58
The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med (1986) 3.27
Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer (2006) 2.76
The prognostic value of kidney transplant center report cards. Am J Transplant (2013) 2.64
A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med (1982) 2.56
Determining the area under the ROC curve for a binary diagnostic test. Med Decis Making (2001) 2.54
A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med (1982) 2.49
Factors predicting recovery of erections after radical prostatectomy. J Urol (2000) 2.44
Risk factors for urinary incontinence after radical prostatectomy. J Urol (1996) 2.42
Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol (2007) 2.26
Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol (1995) 2.19
Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res (1997) 2.16
Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C. Ann Intern Med (1997) 2.09
Fatal encephalitis and myocarditis in young domestic geese (Anser anser domesticus) caused by West Nile virus. Emerg Infect Dis (2001) 2.03
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol (1999) 2.00
PlanAlyzer, an interactive computer-assisted program to teach clinical problem solving in diagnosing anemia and coronary artery disease. Acad Med (1992) 1.96
Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res (1998) 1.95
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. Br J Cancer (2009) 1.77
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology (2001) 1.65
A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice. Cancer Res (2000) 1.64
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy. J Clin Oncol (2001) 1.55
Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology. J Urol (1999) 1.54
A catalog of prostate cancer nomograms. J Urol (2001) 1.51
Self-assembly of subnanometer-diameter single-wall MoS2 nanotubes. Science (2001) 1.47
Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia. Ann Intern Med (1996) 1.43
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol (2001) 1.42
The conjunction fallacy? Mem Cognit (1990) 1.42
Case report: Remote monitoring using Spectrum Medical Live Vue allows improved response time and improved quality of care for patients on cardiopulmonary support. Perfusion (2013) 1.42
Reanalysis of unruptured intracranial aneurysm management: effect of a new international study on the threshold probabilities. Med Decis Making (2001) 1.42
Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology (1997) 1.41
Pathogenicity of West Nile virus for turkeys. Avian Dis (2001) 1.41
Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years. Vet Microbiol (2000) 1.41
Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) on the incidence of invasive cervical cancer. Med Care (1992) 1.40
Managing the extracorporeal membrane oxygenation (ECMO) circuit integrity and safety utilizing the perfusionist as the "ECMO Specialist". Perfusion (2013) 1.39
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol (2000) 1.33
The development of a data security model for the Collaborative Social and Medical Services System. Proc Annu Symp Comput Appl Med Care (1994) 1.32
Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza. Avian Dis (2001) 1.32
The danger of applying group-level utilities in decision analyses of the treatment of localized prostate cancer in individual patients. Med Decis Making (1999) 1.28
Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol (1996) 1.26
Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol (1998) 1.26
Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? J Urol (1997) 1.24
Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Hum Pathol (2001) 1.22
Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (2001) 1.21
Management of prostate-specific antigen relapse in prostate cancer: a European Consensus. Int J Clin Pract (2004) 1.20
A critique of the decision analysis for clinically localized prostate cancer. J Urol (1994) 1.20
Impact of a clinical pathway for radical retropubic prostatectomy. Urology (1998) 1.20
Impulsive terahertz radiation with high electric fields from an amplifier-driven large-area photoconductive antenna. Opt Express (2010) 1.17
Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. J Urol (2000) 1.16
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup. J Urol (2001) 1.15
Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma. Cancer (2001) 1.14
Assessment of the ability of ratite-origin influenza viruses to infect and produce disease in rheas and chickens. Avian Dis (1996) 1.14
Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer. J Natl Cancer Inst (1997) 1.14
Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery. Cancer (1998) 1.13
A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann Thorac Surg (2000) 1.11
Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer. Am J Surg Pathol (2001) 1.10
Predictive model for survival at the conclusion of a damage control laparotomy. Am J Surg (2000) 1.10
Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis (2000) 1.09
Ultrafast transient generation of spin-density-wave order in the normal state of BaFe2As2 driven by coherent lattice vibrations. Nat Mater (2012) 1.09
Nonthermal melting of a charge density wave in TiSe2. Phys Rev Lett (2011) 1.08
The metrics process: Baylor's development of a "report card" for faculty and departments. Acad Med (1999) 1.06
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis. Diabetes Obes Metab (2012) 1.05
Dynamics of photoinduced charge-density-wave to metal phase transition in K0.3MoO3. Phys Rev Lett (2009) 1.05
Morphology effectively controls singlet-triplet exciton relaxation and charge transport in organic semiconductors. Phys Rev Lett (2009) 1.04
Citation analysis of the field of medical decision making: update, 1959-1985. Med Decis Making (1988) 1.03
Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer. J Clin Oncol (1997) 1.03
Primary Gleason pattern as a predictor of disease progression in gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy. Am J Surg Pathol (2001) 1.03
Controlled vaporization of the superconducting condensate in cuprate superconductors by femtosecond photoexcitation. Phys Rev Lett (2008) 1.01
Significant efficiency findings while controlling for the frequent confounders of CAI research in the PlanAlyzer project's computer-based, self-paced, case-based programs in anemia and chest pain diagnosis. J Med Syst (1991) 1.01
Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol (1997) 1.00
Recall and attitudes in patients with prostate cancer. Urology (1999) 1.00
Clinical and morphologic cardiac findings after anthracycline chemotherapy. Analysis of 64 patients studied at necropsy. Am J Cardiol (1983) 1.00
The influence of avoparcin on the establishment of salmonella in chickens. Zentralbl Veterinarmed B (1982) 1.00
Ultrafast dynamics of charge density waves in 4H(b)-TaSe2 probed by femtosecond electron diffraction. Phys Rev Lett (2012) 0.96
Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings. Qual Life Res (2000) 0.96
The CIO and the medical informaticist: alliance for progress. Proc Annu Symp Comput Appl Med Care (1993) 0.96
Energy-gap dynamics of superconducting NbN thin films studied by time-resolved terahertz spectroscopy. Phys Rev Lett (2011) 0.95
Disentanglement of the electronic and lattice parts of the order parameter in a 1D charge density wave system probed by femtosecond spectroscopy. Phys Rev Lett (2010) 0.94
Femtosecond response of quasiparticles and phonons in superconducting YBa(2)Cu(3)O(7-δ) studied by wideband terahertz spectroscopy. Phys Rev Lett (2010) 0.93
A national survey of attitudes regarding participation in prostate carcinoma testing. Cancer (1996) 0.93
Decisions at hand: a decision support system on handhelds. Stud Health Technol Inform (2001) 0.93
Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials. J Urol (2006) 0.92
Postatrophic hyperplasia of the prostate: lack of association with prostate cancer. Am J Surg Pathol (1999) 0.92
Nomograms for predicting graft function and survival in living donor kidney transplantation based on the UNOS Registry. J Urol (2009) 0.92
Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis. Mod Pathol (1999) 0.91
Lymphovascular invasion as a predictor of disease progression in prostate cancer. Am J Surg Pathol (2000) 0.90
Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index. Cancer (1996) 0.90
Biochemical profiles. Applications in ambulatory screening and preadmission testing of adults. Ann Intern Med (1987) 0.90
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases. Clin Cancer Res (1997) 0.90
Treatment of primary peritoneal mesothelioma by hyperthemic intraperitoneal chemotherapy. Perfusion (1999) 0.89
How to evaluate drugs. Cost-effectiveness analysis. JAMA (1990) 0.89
Kinetics of a superconductor excited with a femtosecond optical pulse. Phys Rev Lett (2005) 0.89
Informatics. A subspecialty in pathology. Am J Clin Pathol (1993) 0.89